FI922434A - Produktion av rekombinant human interleukin-1-inhibitor. - Google Patents

Produktion av rekombinant human interleukin-1-inhibitor. Download PDF

Info

Publication number
FI922434A
FI922434A FI922434A FI922434A FI922434A FI 922434 A FI922434 A FI 922434A FI 922434 A FI922434 A FI 922434A FI 922434 A FI922434 A FI 922434A FI 922434 A FI922434 A FI 922434A
Authority
FI
Finland
Prior art keywords
inhibitor
rekombinant
produktion
human interleukin
disclosed
Prior art date
Application number
FI922434A
Other languages
English (en)
Other versions
FI104733B (fi
FI922434A0 (fi
Inventor
Robert Hageman
Stephen P Eisenberg
David Dripps
Ronald Evans
Henryk Cudny
Robert C Thompson
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of FI922434A0 publication Critical patent/FI922434A0/fi
Publication of FI922434A publication Critical patent/FI922434A/fi
Application granted granted Critical
Publication of FI104733B publication Critical patent/FI104733B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI922434A 1989-11-29 1992-05-27 Menetelmä ja plasmidi interleukiini 1:n inhibiittorin tuottamiseksi FI104733B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US44265289A 1989-11-29 1989-11-29
US44265289 1989-11-29
US9006979 1990-11-29
PCT/US1990/006979 WO1991008285A1 (en) 1989-11-29 1990-11-29 Production of recombinant human interleukin-1 inhibitor

Publications (3)

Publication Number Publication Date
FI922434A0 FI922434A0 (fi) 1992-05-27
FI922434A true FI922434A (fi) 1992-05-27
FI104733B FI104733B (fi) 2000-03-31

Family

ID=23757611

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922434A FI104733B (fi) 1989-11-29 1992-05-27 Menetelmä ja plasmidi interleukiini 1:n inhibiittorin tuottamiseksi

Country Status (17)

Country Link
US (1) US5453490A (fi)
EP (1) EP0502956B1 (fi)
JP (1) JP3014007B2 (fi)
KR (1) KR0182819B1 (fi)
AT (1) ATE152172T1 (fi)
AU (1) AU651955B2 (fi)
BR (1) BR9007883A (fi)
CA (1) CA2068320C (fi)
DE (1) DE69030582T2 (fi)
DK (1) DK0502956T3 (fi)
ES (1) ES2103305T3 (fi)
FI (1) FI104733B (fi)
GR (1) GR3024031T3 (fi)
HK (1) HK1006856A1 (fi)
HU (1) HUT64582A (fi)
NO (1) NO305290B1 (fi)
WO (1) WO1991008285A1 (fi)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US6552170B1 (en) * 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US5861476A (en) * 1994-02-02 1999-01-19 Affymax Technologies N.V. Peptides and compounds that bind to the IL-1 receptor
US5786331A (en) * 1994-02-02 1998-07-28 Affymax Technologies N.V. Peptides and compounds that bind to the IL-1 receptor
US5608035A (en) * 1994-02-02 1997-03-04 Affymax Technologies N.V. Peptides and compounds that bind to the IL-1 receptor
US5880096A (en) * 1994-02-02 1999-03-09 Affymax Technologies N.V. Peptides and compounds that bind to the IL-1 receptor
IT1270662B (it) * 1994-10-13 1997-05-07 Applied Research Systems Antagonista della interleuchina-1
US5837495A (en) * 1994-10-13 1998-11-17 Applied Research Systems Ars Holding N.V. DNA encoding interleukin-1 antagonist
US5981713A (en) * 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
ATE406176T1 (de) * 1996-12-06 2008-09-15 Amgen Inc Il-1-inhibitor in kombinationstherapie zur behandlung il-1-vermittelter krankheiten
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US6013253A (en) * 1997-08-15 2000-01-11 Amgen, Inc. Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist
US6660843B1 (en) * 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
EP2087908B1 (en) 2001-06-26 2018-05-30 Amgen Inc. Antibodies to opgl
US20030191056A1 (en) 2002-04-04 2003-10-09 Kenneth Walker Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
CA2497884C (en) 2002-09-06 2013-10-22 Brian Varnum Therapeutic human anti-il-1r1 monoclonal antibody
HUE040595T2 (hu) 2004-04-02 2019-03-28 Swedish Orphan Biovitrum Ab Publ Eljárás IL-1ra aggregációjának csökkentésére
PE20070684A1 (es) 2005-11-14 2007-08-06 Amgen Inc MOLECULAS QUIMERICAS DE ANTICUERPO RANKL-PTH/PTHrP
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
US7767206B2 (en) 2006-10-02 2010-08-03 Amgen Inc. Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
US10105441B2 (en) * 2007-08-16 2018-10-23 The Schepens Eye Research Institute, Inc. Method for inhibiting or reducing dry eye disease by IL-1Ra
WO2009062339A1 (en) 2007-11-14 2009-05-22 General Regeneratives, Ltd. Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
EP2620139B1 (en) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1 receptor antagonist rich solutions
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
CN101690801B (zh) 2009-10-26 2012-08-01 上海交通大学 白细胞介素-1受体拮抗剂的用途及其药物组合物
EP2598526B1 (en) 2010-07-29 2018-09-05 Eleven Biotherapeutics, Inc. Chimeric il-1 receptor type i agonists and antagonists
US20140234330A1 (en) 2011-07-22 2014-08-21 Amgen Inc. Il-17 receptor a is required for il-17c biology
WO2013019652A1 (en) * 2011-07-29 2013-02-07 Eleven Biotherapeutics, Inc. Purified proteins
CN104302772B (zh) 2012-05-18 2017-11-10 爱德迪安（北京）生物技术有限公司 用于糖尿病治疗的蛋白、蛋白缀合物及其应用
DK2968468T3 (en) 2013-03-13 2021-07-26 Buzzard Pharmaceuticals AB Chimeric cytokine formulations for ocular delivery
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9758806B2 (en) 2013-03-15 2017-09-12 Biomet Biologics, Llc Acellular compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
CA2929201A1 (en) 2013-11-11 2015-05-14 Ascendis Pharma Relaxin Division A/S Relaxin prodrugs
EP3074507B1 (en) 2013-11-26 2022-01-05 Biomet Biologics, LLC Methods of mediating macrophage phenotypes
WO2015191783A2 (en) 2014-06-10 2015-12-17 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same
US10041044B2 (en) 2016-07-29 2018-08-07 Trustees Of Boston University Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development
US11285196B2 (en) 2017-03-13 2022-03-29 Eslam Abbas Baseuny Multivalent biologic constructs for inducing a therapeutic modulation of cellular response and uses thereof
WO2020035482A1 (en) 2018-08-13 2020-02-20 Iltoo Pharma Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
WO2023222565A1 (en) 2022-05-16 2023-11-23 Institut National de la Santé et de la Recherche Médicale Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3855747T2 (de) * 1987-08-26 1997-06-12 Biogen Inc Biologische materialien, deren herstellung und verwendung in der therapie
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
US5075222A (en) * 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
WO1991017184A1 (en) * 1990-04-27 1991-11-14 The Upjohn Company Modified interleukin-1 inhibitors
DE69131044T2 (de) * 1990-05-01 1999-11-18 Chiron Corp., Emeryville Interleukin-i antagonist und seine verwendung

Also Published As

Publication number Publication date
ATE152172T1 (de) 1997-05-15
CA2068320A1 (en) 1991-05-30
HU9201777D0 (en) 1992-12-28
HK1006856A1 (en) 1999-03-19
CA2068320C (en) 2000-10-17
EP0502956A1 (en) 1992-09-16
DE69030582T2 (de) 1998-06-25
EP0502956B1 (en) 1997-04-23
AU651955B2 (en) 1994-08-11
NO922138D0 (no) 1992-05-29
EP0502956A4 (en) 1992-12-09
GR3024031T3 (en) 1997-10-31
FI104733B (fi) 2000-03-31
NO305290B1 (no) 1999-05-03
KR920703792A (ko) 1992-12-18
HUT64582A (en) 1994-01-28
JP3014007B2 (ja) 2000-02-28
KR0182819B1 (en) 1999-04-01
US5453490A (en) 1995-09-26
JPH05503007A (ja) 1993-05-27
FI922434A0 (fi) 1992-05-27
WO1991008285A1 (en) 1991-06-13
ES2103305T3 (es) 1997-09-16
AU6900791A (en) 1991-06-26
BR9007883A (pt) 1992-09-29
NO922138L (no) 1992-05-29
DE69030582D1 (de) 1997-05-28
DK0502956T3 (da) 1997-10-20

Similar Documents

Publication Publication Date Title
FI922434A (fi) Produktion av rekombinant human interleukin-1-inhibitor.
IT1182721B (it) Procedimento di purificazione di proteine ossee
DE68925724D1 (de) Nichtkryogene niederdruckverarbeitung zur wiedergewinnung von äthylen
DE3769523D1 (de) Schraubenkompressor.
HUT72187A (en) Recombinant method and host for manufacture of xylitol
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
IT8520350A0 (it) Procedimento ed impianto per la pulitura di gas di scarto.
ITMI920794A0 (it) Procedimento per la produzione di carbone attivo
IT8419730A0 (it) Procedimento per la trasformazione quantitativa di teicoplanina a2fattore 1 in teicoplanina a2fattore 3.
EP0406211A3 (en) Fucosidase inhibitors
IT8622548A0 (it) Procedimento d'epurazione e di deodorizzazione di gas e installazione per la messa in opera di questo procedimento.
IT8721560A0 (it) Procedimento per la purificazione di interferone.
ITMI922551A0 (it) Procedimento per la produzione di carbone attivo
IT9020860A0 (it) Procedimento per la depurazione fine di gas
DE3783092D1 (de) Gaskompressor-steuerung.
IT1230866B (it) Procedimento per la produzione di coke.
KR950702519A (ko) 하이드로플루오로카본의 제조방법(production of hydrofluorocarbons)
IT8719420A0 (it) Purificazione di interleuchina-1umana ricombinante.
IT1231506B (it) Procedimento per la purificazione di polieteri polioli.
AU2885689A (en) Novel proteins derived from human alpha2-plasmin inhibitor orproteins similar thereto
SE9300735L (sv) Startblock
AU7422387A (en) Tumor necrosis factor alpha as treatment for infectious diseases
IT1226147B (it) Processo per la preparazione di perfluoro (2 bromoetilviniletere).
IT1233109B (it) Servo-meccanismo per regolatori di pressione di gas
IT1247508B (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: AMGEN INC.